Panacea Biotec balance sheet

As of Mar 2026

Total assets: ₹1,262cr−2.1% on Mar 2025
Shareholders' equity: ₹829cr−0.2% on Mar 2025
Total debt: ₹23.7cr+6.5% on Mar 2025
Cash and investments: ₹67.3cr−21.0% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	553	543	560	588
	100.0	93.5	74.7	28.0
	15.5	15.8	12.6	0.0
	6.8	7.7	9.2	11.6
	44.1	34.5	26.8	14.3
	0.1	0.1	0.1	0.1
	0.0	0.0	0.1	0.3
	28.2	6.1	3.1	4.9
	28.3	6.2	3.2	5.3
	1.2	43.5	69.0	55.3
	749	745	756	703
	193	214	178	202
	10.0	3.2	40.4	13.4
	73.5	72.6	57.4	60.1
	57.3	82.1	47.2	39.9
	7.1	24.8	92.3	186
	1.9	2.6	3.2	1.6
	60.3	69.0	5.2	59.1
	210	254	246	360
	110	77.3	61.6	0.0
	513	545	485	562
	—	0.0	0.0	6.0
	1,262	1,290	1,241	1,271
Equity
	6.1	6.1	6.1	6.1
	829	829	836	837
	835	835	842	844
	−6.0	−4.2	−3.8	−3.5
	829	831	838	840
Liabilities
	23.7	22.2	21.0	20.2
	0.5	0.5	0.4	—
	24.1	22.7	21.4	20.2
	36.6	35.3	27.8	26.6
	23.1	23.3	22.6	20.4
	0.7	10.9	21.9	32.1
	84.6	92.1	93.6	99.2
	0.0	0.0	0.0	0.1
	190	226	154	177
	10.0	9.4	17.3	20.4
	200	235	171	198
	39.5	36.4	35.7	36.1
	2.0	0.0	0.1	0.6
	108	95.5	102	95.3
	349	367	309	330
	—	0.0	0.0	2.1
	433	459	402	431
	1,262	1,290	1,241	1,271
Trade payables — MSME split
	22.2	14.2	—	—
	167	212	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

PANACEABIO₹329.05

Panacea Biotec Limited

· Pharma & Health

₹ CrorePeersSAIPARENT HIKAL INDOCO DCAL WINDLAS HESTERBIO SOLARA SYNCOMFMcap ₹2,017 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	588.3	560.0	543.4	553.3	553.3
+ Capital Work-in-Progress	28.0	74.7	93.5	100.0	100.0
+ Investment Property	0.0	12.6	15.8	15.5	15.5
+ Other Intangibles	11.6	9.2	7.7	6.8	6.8
+ Intangibles under Development	14.3	26.8	34.5	44.1	44.1
+ Non-current Investments	0.1	0.1	0.1	0.1	0.1
+ Long-term Loans	0.3	0.1	0.0	0.0	0.0
+ Other Non-current Financial Assets	4.9	3.1	6.1	28.2	28.2
Non-current Financial Assets	5.3	3.2	6.2	28.3	28.3
+ Other Non-current Assets	55.3	69.0	43.5	1.2	1.2
Total Non-current Assets	702.9	755.5	744.6	749.1	749.1
Current Assets
+ Inventories	202.1	177.9	213.7	192.8	192.8
+ Current Investments	13.4	40.4	3.2	10.0	10.0
+ Trade Receivables	60.1	57.4	72.6	73.5	73.5
+ Cash & Cash Equivalents	39.9	47.2	82.1	57.3	57.3
+ Other Bank Balances	186.1	92.3	24.8	7.1	7.1
+ Short-term Loans	1.6	3.2	2.6	1.9	1.9
+ Other Current Financial Assets	59.1	5.2	69.0	60.3	60.3
Current Financial Assets	360.2	245.6	254.3	210.1	210.1
+ Other Current Assets	0.0	61.6	77.3	110.1	110.1
Total Current Assets	562.3	485.2	545.2	513.0	513.0
+ Assets Held for Sale	6.0	0.0	0.0	—	—
Total Assets	1,271.2	1,240.7	1,289.8	1,262.2	1,262.2
Equity
+ Equity Share Capital	6.1	6.1	6.1	6.1	6.1
+ Other Equity / Reserves	837.5	835.9	828.7	828.7	828.7
Equity — Owners of Parent	843.6	842.1	834.8	834.8	834.8
+ Minority Interest	-3.5	-3.8	-4.2	-6.0	-6.0
Total Equity	840.1	838.2	830.6	828.9	828.9
Liabilities
+ Borrowings — Non-current	20.2	21.0	22.2	23.7	23.7
+ Other Non-current Financial Liab	—	0.4	0.5	0.5	0.5
Non-current Financial Liabilities	20.2	21.4	22.7	24.1	24.1
+ Provisions — Non-current	26.6	27.8	35.3	36.6	36.6
+ Deferred Tax Liabilities	20.4	22.6	23.3	23.1	23.1
+ Other Non-current Liabilities	32.1	21.9	10.9	0.7	0.7
Non-current Liabilities	99.2	93.6	92.1	84.6	84.6
+ Borrowings — Current	0.1	0.0	0.0	0.0	0.0
+ Trade Payables	177.3	153.7	225.8	189.6	189.6
+ Other Current Financial Liab	20.4	17.3	9.4	10.0	10.0
Current Financial Liabilities	197.7	171.0	235.1	199.6	199.6
+ Provisions — Current	36.1	35.7	36.4	39.5	39.5
+ Current Tax Liabilities	0.6	0.1	0.0	2.0	2.0
+ Other Current Liabilities	95.3	102.0	95.5	107.5	107.5
Current Liabilities	329.7	308.8	367.0	348.7	348.7
+ Liabilities Held for Sale	2.1	0.0	0.0	—	—
Total Liabilities	431.1	402.5	459.1	433.3	433.3
Total Equity & Liabilities	1,271.2	1,240.7	1,289.8	1,262.2	1,262.2
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	14.2	22.2	22.2
+ Dues to Other Creditors — Current	—	—	211.6	167.4	167.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.